Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001144204-07-067647
Filing Date
2007-12-14
Accepted
2007-12-14 16:20:40
Documents
4
Effectiveness Date
2007-12-14

Document Format Files

Seq Description Document Type Size
1 v097166_s8.htm S-8 150787
2 v097166_ex5-1.htm EX-5.1 17016
3 v097166_ex23-1.htm EX-23.1 5154
4 v091766_ex23-2.htm EX-23.2 4051
  Complete submission text file 0001144204-07-067647.txt   178395
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: S-8 | Act: 33 | File No.: 333-148085 | Film No.: 071307630
SIC: 2834 Pharmaceutical Preparations